BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26980476)

  • 1. Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma.
    Chen HI; Tsai HP; Chen YT; Tsao SC; Chai CY
    Pathol Oncol Res; 2016 Oct; 22(4):699-705. PubMed ID: 26980476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
    Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
    Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related proteins LC3 and Beclin-1 impact the efficacy of chemoradiation on esophageal squamous cell carcinoma.
    Chen Y; Li X; Wu X; He C; Guo L; Zhang S; Xiao Y; Guo W; Tan B
    Pathol Res Pract; 2013 Sep; 209(9):562-7. PubMed ID: 23880165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of
    Guo Y; Liu Y; Yang H; Dai N; Zhou F; Yang H; Sun W; Kong J; Yuan X; Gao S
    Pathol Oncol Res; 2021; 27():1609976. PubMed ID: 34955686
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38α- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Liu J; Lv L; Gong J; Tan Y; Zhu Y; Dai Y; Pan X; Huen MSY; Li B; Tsao SW; Huo J; Cheung ALM
    Int J Cancer; 2018 Jan; 142(1):145-155. PubMed ID: 28905993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
    Wan Y; Wu XY
    Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic significance of GPX2 protein expression in esophageal squamous cell carcinoma.
    Lei Z; Tian D; Zhang C; Zhao S; Su M
    BMC Cancer; 2016 Jul; 16():410. PubMed ID: 27388201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy inhibition contributes to radiation sensitization of esophageal squamous carcinoma cells.
    Chen YS; Song HX; Lu Y; Li X; Chen T; Zhang Y; Xue JX; Liu H; Kan B; Yang G; Fu T
    Dis Esophagus; 2011 Aug; 24(6):437-43. PubMed ID: 21166739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression and clinical significance of BRCA1 in human esophageal squamous cell carcinoma].
    Yang YX; Xue LY; Dong LJ; Fu M; Zhan QM; Tong T
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):905-9. PubMed ID: 23336376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
    Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
    Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
    Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
    Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
    Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
    Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Yamashita K; Miyata H; Makino T; Masuike Y; Furukawa H; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
    Ann Surg Oncol; 2017 Dec; 24(13):4025-4032. PubMed ID: 29022200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.